It is a campaign to create awareness of the third most occurring cancer among malaysian men.
Whilst plenty of campaigns are dedicated for women, we decided to initiate an awareness campaign focusing on Malaysian men — since prostate cancer is a silent killer that impacts Only Men.
Men can survive prostate cancer - if detected and treated early. Together, we can beat prostate cancer!
In Malaysia, more than 60% of prostate cancer cases are diagnosed at an advanced stage. We want to raise awareness on the importance of prostate health, risks and symptoms of prostate cancer and encourage early detection of prostate cancer in order to save our men.
There are things #OnlyMenCan do, like surviving prostate cancer — only if detected and treated early.
Vision & Mission
We aim to halve the number of newly-diagnosed advanced prostate cancer cases in Malaysia, from over 60% in 2020 to 30% by 2025.
To achieve this goal, we are committed to raising national awareness about prostate cancer, enhancing the competency of our healthcare professionals, and encouraging early detection and treatment.
The Urological Cancer Trust Fund is a non profit entity under the Faculty of Medicine, Universiti Malaya.
Set up in 2015, the Fund is committed to increasing public awareness of urological cancers particularly prostate cancer, encouraging early detection of prostate cancer and providing financial assistance to under-privileged patients.
“Cancer screening awareness enhances early detection, improving quality of life and saving lives. Let’s beat prostate cancer - TOGETHER.”
Professor Dato' Dr. Yang Faridah Abdul Aziz
Professor Dato’ Dr. Yang Faridah Abdul Aziz, a professor and consultant radiologist, is the Dean of Faculty of Medicine and a senate member at Universiti Malaya. Formerly on the Board of Directors, she plays active roles in the Malaysian Medical Council and the Asian Oceanian Society of Radiology. Her drive for knowledge shapes her commitment to professional and personal growth.
“Prostate cancer is highly treatable and curable. The more research we do, the sooner we can cure more men with prostate cancer.”
Dato’ Sri CP Loo
Dato’ Sri CP Loo has had an impressive career in business consulting; he has also battled cancer. He currently serves on the Board of Trustees of Yayasan Mr. DIY. He is an Independent Commissioner of Mr DIY Indonesia, and an Independent Director of Mr DIY Thailand. He is dedicated to promoting cancer awareness and supporting cancer research.
“With increased awareness of early detection, our men will have a better chance of surviving prostate cancer.”
Dr. Noor Ashani Md.Yusoff
Dr. Noor Ashani Md. Yusoff currently working as Senior Consultant Urologist He has been entrusted to be the Head of Urology Specialty in Ministry of Health Malaysia. He has been appointed as an Adjunct Professor at Hospital Sultan Azlan Shah UPM since year 2000. Currently he is also the President of Malaysia Urological Association (MUA).
His interest mainly in minimally invasive surgery particularly robotic assisted laparoscopic surgery. His robotic surgery training continue at Yonsei Severance Hospital, Seoul, Korea in 2010 under the supervision of Dr. Khoo Hon Rha, the pioneer of robotic surgery in Korea. He has performed more than 400 cases of Robotic Assisted Laparoscopic surgery, from RAL Radical Prostatectomy to RAL Retroperitoneal Lymph Nodes Dissection. He is the pioneer RAL RPLND in Malaysia and has the largest series in South East Asia. He has proctored more than 80 cases of Robotic Assisted Laparoscopic Surgery throughout Malaysia and has been invited to give several talks related to Robotic Assisted Surgery local. or internationally.
“Prostate cancer is highly treatable and curable. The more research we do, the sooner we can cure more men with prostate cancer.”
Assc. Prof. Dr. Marniza Saad
Marniza Saad is a clinical oncologist with deep passion in the management of patients with urological cancers. Together with a team of urologists and oncologists, she leads the genitourinary multidisciplinary team at the Universiti Malaya Medical Centre (GU-MDT UMMC) since it was formed in 2010 on a mission to provide the best care to patients at any stage of their cancer. She runs numerous clinical trials studying cutting edge therapies to improve outcomes in prostate cancer.
Dr. Ahmad Nazran bin Fadzli
Prof. Dr. Ong Teng Aik
